Press release
Top Factor Driving Antidiabetics Market Growth in 2025: Impact Of The Rising Incidence Of Lifestyle Related Conditions On The Growth Of The Antidiabetics Market
Antidiabetics Market Research
The market size of antidiabetics has seen speedy growth in the past few years. It is projected to escalate from $76.03 billion in 2024 to $84.84 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 11.6%. The growth experienced during the previous period can be credited to the surge in global diabetes cases, innovation in drug development, heightened awareness and diagnosis, favourable government regulations, an aging population, inactive lifestyles, and a rise in healthcare spending.
The size of the antidiabetics market is anticipated to witness substantial growth in the coming years, expanding to $130.12 billion in 2029 with a compound annual growth rate (CAGR) of 11.3%. The growth during the predicted period can be credited to factors such as increasing diabetes cases, rising awareness and diagnosis, enhanced spending on healthcare, a growing number of elderly individuals, and government health initiatives and policies. Key trends for the forecast period encompass the growth in GLP-1 receptor agonists and SGLT2 inhibitors, the expansion of biologics and biosimilars, a focus on preventive healthcare, growth in emerging markets, and the integration of technology.
What Factors Are Propelling the Expansion of the Antidiabetics Market?
The uptick in health problems associated with lifestyle habits is projected to boost the antidiabetics market in the future. These lifestyle-related conditions are health complications triggered or worsened by behaviors including unhealthy eating, sedentariness, smoking, and heavy drinking. The prevalence of health issues related to such habits is on the rise due to bad nutrition, lack of physical activity, and mounting stress levels. Antidiabetic drugs can aid in managing lifestyle-induced conditions such as obesity and metabolic syndrome by enhancing insulin responsiveness and regulating blood glucose levels. For instance, the World Health Organization, which is based in Switzerland, revealed in March 2022 that about 1 billion people globally, including 650 million adults, 340 million adolescents, and 39 million children, were experiencing obesity. This figure is growing. By 2025, it is projected that about 167 million adults and children will be suffering health impacts due to being overweight or obese. Therefore, the escalating prevalence of lifestyle-related conditions is fueling growth of the antidiabetic market.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=18225&type=smp
Who Are the Dominant Companies Influencing Antidiabetics Market Trends?
Major companies operating in the antidiabetics market are Pfizer Inc., Johnson & Johnson, Merck & Co. Inc., Bayer AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca plc, Abbott Laboratories, Novartis AG, Takeda Pharmaceutical Company Limited, GSK plc, Eli Lilly and Company, Amgen Inc., Boehringer Ingelheim International GmbH, Gilead Sciences Inc., Novo Nordisk A/S, Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Astellas Pharma Inc., Biogen, Vertex Pharmaceuticals Incorporated, Servier Laboratories, Sun Pharmaceutical Industries Limited, Cipla Limited, Dr. Reddy's Laboratories, Lupin Limited, Torrent Pharmaceuticals Ltd, Biocon Limited, Glenmark Pharmaceuticals Ltd.
How Is the Antidiabetics Market Evolving?
Leading firms in the antidiabetics market are innovating and producing better products including the anti-diabetic biosimilar, aimed at enhancing glycemic control, minimizing the probability of cardiovascular incidents, and providing superior treatment avenues for people with diabetes. An anti-diabetic biosimilar is an equivalent of a pre-approved reference drug used for diabetes treatment, ensuring similar safety, effectiveness, and quality. For example, in January 2024, Glenmark Pharmaceuticals Limited, a pharmaceutical company based in India, introduced the first biosimilar of Liraglutide, an anti-diabetic medication. The Liraglutide biosimilar, marketed as Lirafit, aids in glycemic control for adults suffering from type 2 diabetes mellitus. Clinical studies reveal it reduces glycemic parameters, assists in weight loss, and promotes cardiovascular safety. As a GLP-1 receptor agonist, it elevates glucose-dependent insulin release and curtails unnecessary glucagon secretion. It is internationally certified for the management of type 2 diabetes in adults.
What Are the Different Segmentations in the Antidiabetics Market?
The antidiabetics market covered in this report is segmented -
1) By Drug Class: Insulin, GLP-1 Receptor Agonists, DPP- 4 Inhibitors, SGLT2 Inhibitors, Other Drug Classes,
2) By Diabetes Type: Type 1, Type 2
3) By Patient Population: Antidiabetics For Pediatrics, Antidiabetics For Adults, Antidiabetics For Geriatrics
4) By Route Of Administration: Antidiabetics Administration Through Insulin Syringes Or Insulin Pens, Antidiabetics Administration Through Insulin Pumps, Intravenous Antidiabetics Infusion, Oral Antidiabetics Administration, Other Routes Of Antidiabetics Administration
5) By Distribution Channel: Online Pharmacies, Hospital Pharmacies, Retail Pharmacies
Subsegments:
1) By Insulin: Rapid-Acting Insulin, Short-Acting Insulin, Intermediate-Acting Insulin, Long-Acting Insulin, Premixed Insulin
2) By GLP-1 Receptor Agonists: Exenatide, Liraglutide, Dulaglutide, Semaglutide, Lixisenatide
3) By DPP-4 Inhibitors: Sitagliptin, Saxagliptin, Linagliptin, Alogliptin
4) By SGLT2 Inhibitors: Canagliflozin, Dapagliflozin, Empagliflozin, Ertugliflozin
5) By Other Drug Classes: Sulfonylureas, Thiazolidinediones (TZDs), Alpha-Glucosidase Inhibitors, Meglitinides, GLP-1/Insulin Combination Therapy
Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/antidiabetics-global-market-report
Which Region Is at the Forefront of the Antidiabetics Market?
North America was the largest region in the antidiabetics market in 2023. The regions covered in the antidiabetics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Is Covered In The Antidiabetics Global Market Report?
- Market Size Analysis: Analyze the Antidiabetics Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Antidiabetics Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Antidiabetics Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Antidiabetics Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=18225
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Top Factor Driving Antidiabetics Market Growth in 2025: Impact Of The Rising Incidence Of Lifestyle Related Conditions On The Growth Of The Antidiabetics Market here
News-ID: 3856958 • Views: …
More Releases from The Business Research Company
Surgical Meshes Market Landscape to 2034: Key Forces Shaping the Next Decade of …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Surgical Meshes Market Size By 2025?
In the past few years, the market size of surgical meshes has seen significant growth. It is projected to expand from $2.03 billion in 2024 to $2.18 billion in 2025, indicating a Compound Annual Growth Rate (CAGR) of 7.3%.…
Rehabilitation Equipment Market Poised to Hit $23.97 Billion by 2029 with Accele …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Rehabilitation Equipment Market Size Growth Forecast: What to Expect by 2025?
In recent times, there has been a significant growth in the size of the rehabilitation equipment market. Projected to increase from $17.36 billion in 2024, it is expected to reach $18.49 billion in 2025, with a compound annual…
Future of the Pediatric Neurology Device Market: Strategic Analysis and Forecast …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Pediatric Neurology Device Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The market size for pediatric neurology devices has seen significant expansion in recent years, climbing from $2.5 billion in 2024 to an anticipated $2.65 billion in 2025, reflecting a compound annual growth rate (CAGR)…
Key Trends Influencing the Growth of the Orthokeratology Lens Market in 2025: In …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Orthokeratology Lens Market Through 2025?
The market for orthokeratology lenses has seen a significant increase in size over recent years. It's projected to expand from $2.56 billion in 2024 to $2.75 billion in 2025, with a compound annual growth rate (CAGR) of…
More Releases for Antidiabetic
Antidiabetic Drug Market to See Booming Business Sentiments
Advance Market Analytics published a new research publication on "Antidiabetic Drug Market Insights, to 2030" with 232 pages and enriched with self-explained Tables and charts in presentable format. In the Study you will find new evolving Trends, Drivers, Restraints, Opportunities generated by targeting market associated stakeholders. The growth of the Antidiabetic Drug market was mainly driven by the increasing R&D spending across the world.
Get Free Exclusive PDF Sample Copy of…
Antidiabetic Biosimilars Market Insights, Trends Forecast 2022-28
The global antidiabetic biosimilars market size is expected to reach huge growth during the forecast period 2022 to 2028. In diabetic individuals, anti-diabetics assist manage blood glucose levels. Biguanides, thiazolidinediones, DPP-IV inhibitors, -glucosidase inhibitors, sulfonylureas, insulin, and GLP-1 receptor agonists like exenatide are a few examples of antidiabetics. An FDA-approved biological making is an integral part as a reference product serves as the basis for the approval of a biosimilar…
Antidiabetic Biosimilars Market Expected to Grow Globally
Antidiabetic biosimilars market overview
Antidiabetics help control blood glucose levels in diabetic patients. Various types of antidiabetics include biguanides, thiazolidinediones, DPP-IV inhibitors, α-glucosidase Inhibitors, sulfonylureas, insulin, and GLP-1 receptor agonists such as exenatide. A biosimilar product is biological product that is approved on the basis that it is highly similar to a FDA approved biological product known as a reference product. Biosimilar manufacturers need to generate data from lab testing and…
Antidiabetic Drugs Market and Pipeline Assessment
Diabetes is a major lifestyle disorder affecting millions of individuals globally. The disorder is also linked with other complications such as diabetic retinopathy, diabetic foot ulcers, nephropathy and cardiovascular complications among others. Wide spread global prevalence and rising incidence rate has made the antidiabetic drugs market attractive for pharmaceutical drug manufacturers. Introduction of superior products in the recent past and increasing patient compliance are other factors driving the diabetes treatment…
Global Antidiabetic Thiazolidinediones Market Research Report 2017
The research report on the global Antidiabetic Thiazolidinediones market studies the market in the past based on which estimates are presented for the future. The report looks into vital market indicators, trends, and opportunities that will have a bearing on the development of this market.
The report begins with an outline of terms and terminologies, classifications, and applications that are standard conventions in the global Antidiabetic Thiazolidinediones market. A glance into…
Antidiabetic Biosimilars Market, Company Analysis and Forecast to 2024
Antidiabetic biosimilars market overview
Antidiabetics help control blood glucose levels in diabetic patients. Various types of antidiabetics include biguanides, thiazolidinediones, DPP-IV inhibitors, α-glucosidase Inhibitors, sulfonylureas, insulin, and GLP-1 receptor agonists such as exenatide. A biosimilar product is biological product that is approved on the basis that it is highly similar to a FDA approved biological product known as a reference product. Biosimilar manufacturers need to generate data from lab testing and…
